Dianthus Therapeutics, Inc. /DE/ (DNTH)
Since Aug 09, 2018, Dianthus Therapeutics, Inc. /DE/ (DNTH) has reported earnings 31 times. On average the shares move ±4.76% post-earnings, with a positive reaction 61.3% of the time. Its largest post-earnings gain was +21.52% (Mar 09, 2026) and its largest decline was -7.05% (May 06, 2021). The next earnings report is predicted for 2026-11-06 (estimated).
Earnings reactions
How DNTH moved on each past earnings report.
Earnings Impact
Total Earnings
31
Avg Abs. Movement
±4.76%
Positive %
61.3%
Negative %
38.7%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 04, 2026 | ☽ POST | +1.57% | open_in_new |
| May 05, 2026 | ☽ POST | +0.19% | open_in_new |
| Mar 09, 2026 | ☀ PRE | +21.52% | open_in_new |
| Nov 05, 2025 | ☽ POST | +8% | open_in_new |
Earnings Count
31
Total earnings in dataset
Avg Abs. Movement
±4.76%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260903 | open_in_new SEC.gov |
| 144 | 20260901 | open_in_new SEC.gov |
| 4 | 20260819 | open_in_new SEC.gov |
| 4 | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260813 | open_in_new SEC.gov |
| 4 | 20260811 | open_in_new SEC.gov |
| 4 | 20260811 | open_in_new SEC.gov |
| 4 | 20260811 | open_in_new SEC.gov |
| 144 | 20260810 | open_in_new SEC.gov |
Frequently asked about DNTH earnings
When does Dianthus Therapeutics, Inc. /DE/ report earnings next? expand_more
Dianthus Therapeutics, Inc. /DE/ (DNTH)'s next earnings date is estimated for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DNTH stock move after earnings? expand_more
Over 31 reports, DNTH has moved an average of ±4.76% the session after earnings, closing higher 61.3% of the time.
What was DNTH's biggest post-earnings move? expand_more
DNTH's largest post-earnings gain on record was +21.52% on Mar 09, 2026, and its largest decline was -7.05% on May 06, 2021.
Where can I find Dianthus Therapeutics, Inc. /DE/'s SEC filings? expand_more
All of Dianthus Therapeutics, Inc. /DE/'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right